News & Media

Displaying 1 - 20 of 54
September 15, 2020

With funding from the CNM and NIH, UCSD researchers discover how Covid-19 enters cells.

May 14, 2020

Research scientists and physicians, including the CNM director and collaborators, provide insights into Covid-19 vaccine development and apply for NIH funding to determine how to disrupt viral binding to human receptors.

February 18, 2020

The Wille Family Foundation has provided another generous donation to support the Center for Nanomedicine.

March 25, 2019

Since newborn babies haven’t encountered many pathogens, they haven’t yet built up a fully robust immune response. But they do have what’s known as “innate immunity” — a collection of bacteria-busting molecules and cells we’re all born with, such as neutrophils and macrophages.

More recently, scientists have come to appreciate another member of the innate immune system: platelets. Better known for their role in clotting blood, it turns out platelets also help keep the bloodstream clear of bacteria. For example, platelets can directly kill Staphylococcus aureus (staph bacteria), a common but sometimes life-threatening microbe.

February 13, 2019

The Mizutani Foundation for Glycoscience’s Board of Directors has selected the UCSB Center for Nanomedicine to receive research grant funding to further explore the interface between pathogens and their hosts at the molecular and nanoscale levels.

October 10, 2018

UCSB, UCSD and SBP researchers trace the complex and variable pathways to the deadly condition known as sepsis

September 20, 2018

A new app developed by UCSB researchers enables a smartphone to ID bacteria in just one hour.

January 24, 2018

The Wille Family Foundation has made another generous donation to the Center for Nanomedicine, which supports the CNM’s research to discover and prevent the origins of common grievous diseases.

December 21, 2017

A startling discovery published today in the journal Science reveals how your past history of minor bacterial infections can add up with age to cause a severe inflammatory disease.

November 10, 2017

Peptide recognizes vasculature associated with brain inflammation

October 02, 2017

The Karl Meyer Award was established in 1990 to honor the distinguished career of Karl Meyer and his outstanding contributions to the field of Glycobiology. This international award is given to well-established scientists with currently active research programs who have made widely recognized major contributions to the field of Glycobiology.

June 06, 2017

When a patient is prescribed the wrong antibiotic to treat a bacterial infection, it’s not necessarily the physician who is at fault. The current antibiotic assay — standardized in 1961 by the World Health Organization and used worldwide — is potentially flawed.

February 08, 2017

For the fifth consecutive year, the Wille Family Foundation has provided a generous donation to support the Center for Nanomedicine.

July 19, 2016

UCSB scientists collaborate with multiple institutions to conduct biomedical research on
infectious disease and sepsis, thanks to a $12.8 million grant

By Julie Cohen

June 28, 2016

A new study led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) describes a technology that could lead to new therapeutics for traumatic brain injuries. The discovery, published in Nature Communications, provides a means of homing drugs or nanoparticles to injured areas of the brain.

June 07, 2016

The Center for Nanomedicine enthusiastically welcomes two top-ranked research and clinical scientists as new members of our center.  Both will participate as inter-institutional adjunct professors.  Their expertise complements CNM biomedical research programs to identify the causes of disease at the nanoscale and molecular level needed to develop more effective diagnostics and therapeutics.

Photo Credit:  Lynda Harris, University of Manchester.     targeted drug deliver, placenta, tumor-homing peptides, research
May 10, 2016

UCSB scientists provide proof of principle for safe, targeted delivery of drugs to the placenta during pregnancy.

January 16, 2016

For the fourth consecutive year, the Wille Family Foundation has provided a generous donation to the Center for Nanomedicine.